100 related articles for article (PubMed ID: 17584664)
1. [Effects of leflunomide combined with hormone therapy for refractory IgA nephropathy].
Rong L; Liu ZR
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):893-4. PubMed ID: 17584664
[TBL] [Abstract][Full Text] [Related]
2. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
Min L; Wang Q; Cao L; Zhou W; Yuan J; Zhang M; Che X; Mou S; Fang W; Gu L; Zhu M; Wang L; Yu Z; Qian J; Ni Z
Oncotarget; 2017 Jul; 8(29):48375-48384. PubMed ID: 28415636
[TBL] [Abstract][Full Text] [Related]
3. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
Cheng G; Liu D; Margetts P; Liu L; Zhao Z; Liu Z; Tang L; Fang Y; Li H; Guo Y; Chen F; Liu F
Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome.
Liu XW; Li DM; Xu GS; Sun SR
Int J Clin Pharmacol Ther; 2010 Aug; 48(8):509-13. PubMed ID: 20650041
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial.
Wu J; Duan SW; Sun XF; Li WG; Wang YP; Liu WH; Zhang JR; Lun LD; Li XM; Zhou CH; Li JJ; Liu SW; Xie YS; Cai GY; Ma L; Huang W; Wu H; Jia Q; Chen XM
Chin Med J (Engl); 2016 Aug; 129(16):1894-903. PubMed ID: 27503012
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy.
Lou T; Wang C; Chen Z; Shi C; Tang H; Liu X; Yin P; Yu X
Nephrology (Carlton); 2006 Apr; 11(2):113-6. PubMed ID: 16669971
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial.
Ni Z; Zhang Z; Yu Z; Lu F; Mei C; Ding X; Yuan W; Zhang W; Jiang G; Sun M; He L; Deng Y; Pang H; Qian J
Ren Fail; 2021 Dec; 43(1):1214-1221. PubMed ID: 34396911
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis.
Zhang D; Xia B; Zhang X; Liang P; Hu X
BMC Urol; 2024 Mar; 24(1):56. PubMed ID: 38468247
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
[TBL] [Abstract][Full Text] [Related]
10. Combination regimen of leflunomide plus methylprednisolone in a female patient with reactive arthritis and concomitant IgA nephropathy.
Chen YZ; Zhao XZ; Wu J; Mei CL
Chin Med J (Engl); 2010 Feb; 123(3):375-8. PubMed ID: 20193265
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis.
Yi J; He Z; Xu S; Feng S
Int Urol Nephrol; 2019 Nov; 51(11):1987-1998. PubMed ID: 31515666
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: a multicenter, randomized, controlled study.
Xie Y; Huang S; Wang L; Miao L; Zhang A; Li Y; Wu X; Wang L; Liu S; Lie C; Chen P; Chen X
Am J Med Sci; 2011 May; 341(5):367-72. PubMed ID: 21293249
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of leflunomide combined with prednisone in the treatment of refractory nephrotic syndrome.
Liu Y; Qu X; Chen W; Zhang Y; Liu L
Ren Fail; 2016 Nov; 38(10):1616-1621. PubMed ID: 27819170
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S
Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of leflunomide combined with corticosteroids for the treatment of IgA nephropathy: a Meta-analysis of randomized controlled trials.
Lv G; Ming C
Ren Fail; 2022 Dec; 44(1):1011-1025. PubMed ID: 35786300
[TBL] [Abstract][Full Text] [Related]
17. Treatment of IgA nephropathy of adults presented by nephrotic syndrome.
Rasić S; Uncanin S; Aganović K; Rasić I; Dzemidzić J; Muslimović A
Bosn J Basic Med Sci; 2008 Aug; 8(3):230-3. PubMed ID: 18816254
[TBL] [Abstract][Full Text] [Related]
18. [IgA nephropathy - prognostic factors and treatment].
Wieliczko M; Dylewska M
Wiad Lek; 2016; 69(5):707-710. PubMed ID: 28033590
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy.
Li Y; Xiong Y; Huang T; Liu X; Xu G
BMC Nephrol; 2021 Nov; 22(1):364. PubMed ID: 34736419
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy in patients with IgA nephropathy.
Peters HP; van den Brand JA; Berger SP; Wetzels JF
Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
